Researchers in Norway have published results from an early stage clinical study looking at the potential of a dietary supplement for people with Parkinson's.
The NADPARK study, a phase 1 clinical trial in newly diagnosed people with Parkinson's, showed promising signs that vitamin B3 supplements may have protective effects on the brain.